Anti-migraine Head Patch - HeadaTerm - Receives FDA Clearance

VANCOUVER, British Columbia, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- WAT Medical's innovative technology to treat all primary headaches, HeadaTerm, received its FDA clearance in September 2018. This product, already approved by CE, HC,... Devices, Neurology, FDA WAT Medical Enterprise, HeadaTerm, neuromodulation, migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news